Navigation Links
Innovative BioDefense Introduces Zylast Antiseptic Lotion
Date:7/30/2013

LAKE FOREST, Calif., July 30, 2013 /PRNewswire/ -- Innovative BioDefense Inc., the developer of a full product line of Zylast™ antiseptic products for use in healthcare, nursing, food preparation, schools, cruise ships, and homes, introduces Zylast Lotion, available in 2 & 8 oz bottles, or in ADA-approved, wall-mounted dispensers.  Zylast Lotion is protected by patents and other intellectual property and can be viewed at http://bit.ly/12nLtjt

In clinical and laboratory studies, Zylast Lotion has been demonstrated to kill very rapidly a wide spectrum of germs, including E. Coli (99.9999%), S. Aureus (99.9997%), K. Pneumoniae (99.9999%), and S. Pyogenes (99.9999%), while being persistent for six hours after application.  The active ingredient is benzethonium chloride (BZT, 0.2%), together with a proprietary blend of adjuvants that enhance the persistence and rapid kill.  Innovative BioDefense has posted Time-Kill and Persistence papers on its website at www.zylast.com with information on the study results.

Clinical studies have shown that use of Zylast Lotion reduces illness absenteeism in schools by 41.6% among students and 24.7% among teachers and staff.  The Lotion is all-natural, water-based, and Triclosan-free.

"First, the Zylast products are persistent for six hours, so children are protected beyond the 15-second lifespan of an alcohol sanitizer.  Second, the Zylast Lotion is effective against pathogens like the Norovirus, rotavirus, and the common cold – some of the most prevalent diseases among children, and germs against which alcohol sanitizers are relatively ineffective.  Finally, the product is water-based and moisturizes the hands, so children and staff actually like using it, which greatly improves compliance." – Dr. Beth McNichol

Zylast Lotion should be used by healthcare and dental workers, teachers and school personnel, food preparers and servers, parents and in long-term care facilities in order to help assure that harmful bacteria and viruses are killed and the likelihood of contagion reduced.

The retail cost of Zylast Lotion is $71.52 for a case (24 bottles) of 2 ounce bottles or $2.98 a bottle; $106.56 for a case (12) of 8 ounce bottles or $8.88 a bottle; or 178.26 for a case (six) of 1,000 ml (33.8 ounce) cartridges for wall mounting or $29.71 a cartridge. Automatic and manual dispensers are also available.

The product is available for immediate delivery and can be ordered by visiting www.zylastdirect.com.

About Zylast
Zylast™ is a developer, manufacturer and marketer of a full line of antiseptic products for use by healthcare professionals, businesses and consumers.  Zylast products, based on proprietary and patented combinations of pharmaceutical ingredients, are owned by Innovative BioDefense Inc., a privately held company headquartered in Lake Forest, CA. 

For more information, visit www.zylast.com.


'/>"/>
SOURCE Innovative BioDefense Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Innovative Cancer Treatment Supported by NICE
2. Innovative Krebsbehandlung wird von NICE unterst├╝tzt
3. UBM Canon and MD+DI Proudly Announce 27 Innovative Products as Winners of the 2013 Medical Design Excellence Awards
4. Andrews Institute offers innovative technology for spine surgery
5. Sirtex To Distribute Surefire Medicals Innovative Infusion System in Australia and Asia Pacific Markets
6. Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies
7. Romanoff Joins Innovative Statewide Program to Combat Abuse of Prescription Pain Medications
8. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
9. BlueBin Inc. Launches to Deliver Innovative Overhaul for Ailing Healthcare Supply Chain
10. VUCA Health Announces Rapid Adoption of its MedsOnCue Digital Patient Engagement Solution Supporting Health Literacy by Innovative Pharmacies across 19 States
11. TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):